Word: abbotts
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...initial research was funded by a $4 million federal grant, American consumers today pay two to five times more for Xalatan than their Europe counterparts. Norvir, a critical AIDS medication, was also developed with the help of taxpayer dollars. It too has earned millions for its manufacturer, Abbott Laboratories. But seeking bigger profits, Abbott raised the price of Norvir by an unprecedented 400 percent last December...
...AIDS activists; other big name pharmaceutical companies–like Bristol-Myers Squibb and GlaxoSmithKline–are also livid. These companies produce AIDS drugs that must be combined with Norvir for optimal efficacy, so the Norvir price increase effectively raises the cost of their drugs as well. But Abbott has declined to pass along the Norvir price hike to its own combination drug, Kaletra (which is pre-boosted with Norvir), thereby undercutting its competitors. A savvy business move? Certainly. Kaletra will doubtless gain increased market share as higher Norvir prices force AIDS patients to switch off of their...
...drugs currently on the market. And a closer look at company balance sheets reveals that the pharmaceutical industry spends 27 percent of its revenues on marketing, compared to a paltry 11 percent on R&D (Pfizer spends 35 percent on marketing and only 15 percent on R&D; Abbott is no better, spending 23 percent on marketing and 10 percent on R&D). To top it off, the pharmaceutical industry is also the world’s most profitable, raking in three times the Fortune 500 average...
Harvard’s most frustrating power play came in the third period, after Cornell’s Shane Hynes scored at 5:09. Chris Abbott went off for tripping 29 seconds later, but the only shot on goal during the ensuing power play came from Abbott’s twin brother Cam, who stole a pass from Pettit to Welch and had his breakaway chance turned aside by Harvard junior goaltender Dov Grumet-Morris...
Harvard’s loss meant that another fine performance from Grumet-Morris was wasted. Improving on his previous night’s success against Colgate, Grumet-Morris stopped a number of close chances, including an odd-man break by Big Red winger Cam Abbott midway through the third period...